Cargando…

Impact of information letters on the reporting rate of adverse drug reactions and the quality of the reports: a randomized controlled study

BACKGROUND: Spontaneous reporting of adverse drug reactions (ADRs) is an important method for pharmacovigilance, but under-reporting and poor quality of reports are major limitations. The aim of this study was to evaluate if repeated one-page ADR information letters affect (i) the reporting rate of...

Descripción completa

Detalles Bibliográficos
Autores principales: Johansson, Marie-Louise, Hägg, Staffan, Wallerstedt, Susanna M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3182972/
https://www.ncbi.nlm.nih.gov/pubmed/21899766
http://dx.doi.org/10.1186/1472-6904-11-14
_version_ 1782212958200266752
author Johansson, Marie-Louise
Hägg, Staffan
Wallerstedt, Susanna M
author_facet Johansson, Marie-Louise
Hägg, Staffan
Wallerstedt, Susanna M
author_sort Johansson, Marie-Louise
collection PubMed
description BACKGROUND: Spontaneous reporting of adverse drug reactions (ADRs) is an important method for pharmacovigilance, but under-reporting and poor quality of reports are major limitations. The aim of this study was to evaluate if repeated one-page ADR information letters affect (i) the reporting rate of ADRs and (ii) the quality of the ADR reports. METHODS: All 151 primary healthcare units in the Region Västra Götaland, Sweden, were randomly allocated (1:1) to an intervention (n = 77) or a control group (n = 74). The intervention consisted of one-page ADR information letters administered at three occasions during 2008 to all physicians and nurses in the intervention units. The number of ADR reports received from the 151 units was registered, as was the quality of the reports, which was defined as high if the ADR was to be reported according to Swedish regulations, that is, if the ADR was (i) serious, (ii) unexpected, and/or (iii) related to the use of new drugs and not labelled as common in the Summary of Product Characteristics. A questionnaire was administered to evaluate if the ADR information letter had reached the intended recipient. RESULTS: Before the intervention, no significant differences in reporting rate or number of high quality reports could be detected between the randomization groups. In 2008, 79 reports were sent from 37 intervention units and 52 reports from 30 control units (mean number of reports per unit ± standard deviation: 1.0 ± 2.5 vs. 0.7 ± 1.2, P = 0.34). The number of high quality reports was higher in intervention units than in control units (37 vs. 15 reports, 0.5 ± 0.9 vs. 0.2 ± 0.6, P = 0.048). According to the returned questionnaires (n = 1,292, response rate 57%), more persons in the intervention than in the control group had received (29% vs. 19%, P < 0.0001) and read (31% vs. 26%, P < 0.0001) an ADR information letter. CONCLUSIONS: This study suggests that repeated ADR information letters to physicians and nurses do not increase the ADR reporting rate, but may increase the number of high quality reports.
format Online
Article
Text
id pubmed-3182972
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-31829722011-09-30 Impact of information letters on the reporting rate of adverse drug reactions and the quality of the reports: a randomized controlled study Johansson, Marie-Louise Hägg, Staffan Wallerstedt, Susanna M BMC Clin Pharmacol Research Article BACKGROUND: Spontaneous reporting of adverse drug reactions (ADRs) is an important method for pharmacovigilance, but under-reporting and poor quality of reports are major limitations. The aim of this study was to evaluate if repeated one-page ADR information letters affect (i) the reporting rate of ADRs and (ii) the quality of the ADR reports. METHODS: All 151 primary healthcare units in the Region Västra Götaland, Sweden, were randomly allocated (1:1) to an intervention (n = 77) or a control group (n = 74). The intervention consisted of one-page ADR information letters administered at three occasions during 2008 to all physicians and nurses in the intervention units. The number of ADR reports received from the 151 units was registered, as was the quality of the reports, which was defined as high if the ADR was to be reported according to Swedish regulations, that is, if the ADR was (i) serious, (ii) unexpected, and/or (iii) related to the use of new drugs and not labelled as common in the Summary of Product Characteristics. A questionnaire was administered to evaluate if the ADR information letter had reached the intended recipient. RESULTS: Before the intervention, no significant differences in reporting rate or number of high quality reports could be detected between the randomization groups. In 2008, 79 reports were sent from 37 intervention units and 52 reports from 30 control units (mean number of reports per unit ± standard deviation: 1.0 ± 2.5 vs. 0.7 ± 1.2, P = 0.34). The number of high quality reports was higher in intervention units than in control units (37 vs. 15 reports, 0.5 ± 0.9 vs. 0.2 ± 0.6, P = 0.048). According to the returned questionnaires (n = 1,292, response rate 57%), more persons in the intervention than in the control group had received (29% vs. 19%, P < 0.0001) and read (31% vs. 26%, P < 0.0001) an ADR information letter. CONCLUSIONS: This study suggests that repeated ADR information letters to physicians and nurses do not increase the ADR reporting rate, but may increase the number of high quality reports. BioMed Central 2011-09-07 /pmc/articles/PMC3182972/ /pubmed/21899766 http://dx.doi.org/10.1186/1472-6904-11-14 Text en Copyright ©2011 Johansson et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Johansson, Marie-Louise
Hägg, Staffan
Wallerstedt, Susanna M
Impact of information letters on the reporting rate of adverse drug reactions and the quality of the reports: a randomized controlled study
title Impact of information letters on the reporting rate of adverse drug reactions and the quality of the reports: a randomized controlled study
title_full Impact of information letters on the reporting rate of adverse drug reactions and the quality of the reports: a randomized controlled study
title_fullStr Impact of information letters on the reporting rate of adverse drug reactions and the quality of the reports: a randomized controlled study
title_full_unstemmed Impact of information letters on the reporting rate of adverse drug reactions and the quality of the reports: a randomized controlled study
title_short Impact of information letters on the reporting rate of adverse drug reactions and the quality of the reports: a randomized controlled study
title_sort impact of information letters on the reporting rate of adverse drug reactions and the quality of the reports: a randomized controlled study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3182972/
https://www.ncbi.nlm.nih.gov/pubmed/21899766
http://dx.doi.org/10.1186/1472-6904-11-14
work_keys_str_mv AT johanssonmarielouise impactofinformationlettersonthereportingrateofadversedrugreactionsandthequalityofthereportsarandomizedcontrolledstudy
AT haggstaffan impactofinformationlettersonthereportingrateofadversedrugreactionsandthequalityofthereportsarandomizedcontrolledstudy
AT wallerstedtsusannam impactofinformationlettersonthereportingrateofadversedrugreactionsandthequalityofthereportsarandomizedcontrolledstudy